Mildly reduced alpha-1 antitrypsin levels are not associated with chronic airflow limitation, emphysema, or respiratory symptoms
Abstract Severe Alpha-1-antitrypsin (AAT) deficiency is a risk factor for chronic obstructive pulmonary disease and emphysema, but risks in mildly reduced AAT levels are unclear. We evaluated the association between mildly reduced serum-AAT levels and chronic airflow limitation (CAL), emphysema and respiratory symptoms, and risks in relation to smoking. We measured serum AAT in people aged 50–65 years in the population-based Swedish CArdioPulmonary bioImage Study (SCAPIS, n = 24,931). We carried out binary logistic regression models to assess pulmonary and cardiovascular outcomes associated with mildly reduced AAT levels. In total, 23,072 individuals had normal serum AAT concentration (≥ 0.86 g/L in men and ≥ 0.94 g/L in women), and 1,859 had mildly reduced AAT levels (0.61–0.85 g/L in men and 0.61–0.93 g/L in women). Mildly reduced AAT levels were not significantly associated with CAL, defined according to either GOLD criteria (CAL GOLD ) or the lower limit of normal (CAL LLN ), or with emphysema on computed tomography (CT): OR (95% CI) 1.01 (0.85–1.21) for CAL GOLD , 0.95 (0.80–1.13) for CAL LLN , and 0.94 (0.75–1.18) for emphysema. Mildly reduced AAT levels were associated with lower odds of DLCO < LLN (OR 0.71, 95% CI 0.57–0.87) and lower odds of respiratory symptoms (0.87 (0.78–0.97) compared with normal AAT levels. In this large population-based cohort, mildly reduced AAT levels were not independently associated with CAL or CT-defined emphysema. These findings suggest that mildly reduced AAT levels alone may not represent a major risk factor for airflow limitation or emphysema in the general population.
Authors
- Anna Moberg (ORCID: https://orcid.org/0000-0002-1135-2744)
- Jonas Eriksson Ström (ORCID: https://orcid.org/0000-0002-3434-988X)
- Eeva Piitulainen
- Zoltán Szabó (ORCID: https://orcid.org/0000-0001-9292-6617)
- Christer Janson
- Suneela Zaigham (ORCID: https://orcid.org/0000-0002-9132-5665)
- Adriana-Maria Hiller (ORCID: https://orcid.org/0000-0002-5452-0314)
- Sköld Magnus
- Anders Blomberg (ORCID: https://orcid.org/0000-0002-1260-3920)
- John Brandberg
- Eva Swahn
- Magnus Ekström
- Åse Johnsson
- Annelie Behndig
- Apostolos Bossios
- Kjell Toren
- Hanan Tanash
- Maria Mannila
- Anders Andersson
- Ulf Nilsson
- Eva Lindberg
- Andrei Malinovschi
- Ida Pesonen
Institutions
- Linköping University (SE)
- Uppsala University (SE)
- Karolinska University Hospital (SE)
- Lund University (SE)
- Sahlgrenska University Hospital (SE)
- Karolinska Institutet (SE)
- Region Västra Götaland (SE)
- Skåne University Hospital (SE)
- Region Skåne (SE)
- University of Gothenburg (SE)
- Umeå University (SE)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1038/s41598-026-79511-0
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- VINNOVA
- Lunds Universitet
- Linköpings Universitet
- Karolinska Institutet
- Knut och Alice Wallenbergs Stiftelse
- Vetenskapsrådet
- Umeå Universitet
- Sahlgrenska Universitetssjukhuset
- Göteborgs Universitet
- Uppsala Universitet
- Skånes universitetssjukhus